Abstract
This study investigated whether an increased use of hormone replacement therapy (HRT) is attributable to a growing motivation among women to use the therapy for disease prevention. Compared with earlier studies, results from this community survey of women aged 51 to 57 years revealed an increased use of HRT, 60% of women had tried HRT, with a median of four years' duration of use. The most frequently cited primacy use for HRT was symptom relief although many women also took the therapy for the prevention of osteoporosis. While women generally commence HRT for symptom relief the extended use of the therapy is, in part, likely to be attributable to an increased motivation among women to remain on HRT for its 'added' benefit of preventing osteoporosis.
Full Text
The Full Text of this article is available as a PDF (53.9 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Ettinger B., Genant H. K., Cann C. E. Long-term estrogen replacement therapy prevents bone loss and fractures. Ann Intern Med. 1985 Mar;102(3):319–324. doi: 10.7326/0003-4819-102-3-319. [DOI] [PubMed] [Google Scholar]
- Griffiths F., Convery B. Women's use of hormone replacement therapy for relief of menopausal symptoms, for prevention of osteoporosis, and after hysterectomy. Br J Gen Pract. 1995 Jul;45(396):355–358. [PMC free article] [PubMed] [Google Scholar]
- Kuh D., Hardy R., Wadsworth M. Social and behavioural influences on the uptake of hormone replacement therapy among younger women. BJOG. 2000 Jun;107(6):731–739. doi: 10.1111/j.1471-0528.2000.tb13333.x. [DOI] [PubMed] [Google Scholar]
- McKinlay S. M., Brambilla D. J., Posner J. G. The normal menopause transition. Maturitas. 1992 Jan;14(2):103–115. doi: 10.1016/0378-5122(92)90003-m. [DOI] [PubMed] [Google Scholar]
- Moorhead T., Hannaford P., Warskyj M. Prevalence and characteristics associated with use of hormone replacement therapy in Britain. Br J Obstet Gynaecol. 1997 Mar;104(3):290–297. doi: 10.1111/j.1471-0528.1997.tb11456.x. [DOI] [PubMed] [Google Scholar]
- Pitt F. A., Brazier J. Hormone replacement therapy for osteoporosis. Lancet. 1990 Apr 21;335(8695):978–978. doi: 10.1016/0140-6736(90)91046-d. [DOI] [PubMed] [Google Scholar]
- Roberts P. J. The menopause and hormone replacement therapy: views of women in general practice receiving hormone replacement therapy. Br J Gen Pract. 1991 Oct;41(351):421–424. [PMC free article] [PubMed] [Google Scholar]
- Stampfer M. J., Colditz G. A. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med. 1991 Jan;20(1):47–63. doi: 10.1016/0091-7435(91)90006-p. [DOI] [PubMed] [Google Scholar]
- Tang M. X., Jacobs D., Stern Y., Marder K., Schofield P., Gurland B., Andrews H., Mayeux R. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet. 1996 Aug 17;348(9025):429–432. doi: 10.1016/S0140-6736(96)03356-9. [DOI] [PubMed] [Google Scholar]